Therapeutic composition
OwnerRichard Luduenainventor
Life of this patent
Estimating the term…
Abstract
An anti-mitotic composition with a therapeutic index greater than 1.1, a clonogenic survival rate of less than 0.1 percent, and a binding affinity index for a class II, a class III, or a class V beta tubulin isotype of at least about 1.1.
Claims20
An anti-mitotic composition with a therapeutic index greater than 1.1, a clonogenic survival rate of less than 0.1 percent, and a binding affinity index for a beta tubulin isotype selected from the group consisting of the class II isotype, the class III isotype, and the class V isotype. one at least about 1.1.
The anti-mitotic composition as recited in daim 2, wherein said beta-tubulin isotype is the class II isotype.
Dependencies are inferred from the claim text.